Contact
searchSearch
HMP Global

March 2017 - FRMC

Department

News Connection
Spiriva Respimat Approved for Children 6 and Up
03/20/2017
The FDA broadened the approval of Spiriva Respimat (tiotropium bromide; Boehringer Ingelheim) inhalation spray to include children 6 and older.
The FDA broadened the approval of Spiriva Respimat (tiotropium bromide; Boehringer Ingelheim) inhalation spray to include children 6 and older.
The FDA broadened the approval...
03/20/2017
First Report Managed Care
News Connection
Industry-Funded Postmarket Studies May Not Appropriately Measure Safety
03/20/2017
A study suggests that due to small sample sizes and potential conflicts of interest, manufacturer-funded studies of approved drugs may not be accurate.
A study suggests that due to small sample sizes and potential conflicts of interest, manufacturer-funded studies of approved drugs may not be accurate.
A study suggests that due to...
03/20/2017
First Report Managed Care
News Connection
ED Patients of Frequent Opioid Prescribers Often Become Long-Term Users
03/20/2017
Long-term opioid painkiller use appears more common among emergency department patients treated by physicians with higher opioid prescription rates.
Long-term opioid painkiller use appears more common among emergency department patients treated by physicians with higher opioid prescription rates.
Long-term opioid painkiller use...
03/20/2017
First Report Managed Care
News Connection
CMS Data Reveals Accelerating US Health Care Costs
03/20/2017
Nationwide health costs are expected to increase an average of 5.6% annually and will account for nearly 20% of the US economy by 2025.
Nationwide health costs are expected to increase an average of 5.6% annually and will account for nearly 20% of the US economy by 2025.
Nationwide health costs are...
03/20/2017
First Report Managed Care
News Connection
New Low Back Pain Guidelines Recommend Nonprescription Treatments First
03/20/2017
The American College of Physicians (ACP) recently issued new clinical guidelines recommending that physicians avoid prescribing pain management drugs when treating acute or subacute low back pain. 
The American College of Physicians (ACP) recently issued new clinical guidelines recommending that physicians avoid prescribing pain management drugs when treating acute or subacute low back pain. 
The American College of...
03/20/2017
First Report Managed Care
News Connection
“Chatbot” Tool Helps Improve Delivery of Care
03/20/2017
A team of hospitalists, radiation oncologists, and interventional radiologists at the University of California at Los Angeles (UCLA) is testing an artificial intelligence prototype that acts as a virtual consultant, providing timely,...
A team of hospitalists, radiation oncologists, and interventional radiologists at the University of California at Los Angeles (UCLA) is testing an artificial intelligence prototype that acts as a virtual consultant, providing timely,...
A team of hospitalists,...
03/20/2017
First Report Managed Care
News Connection
Low-Cost Medication Reminder Devices Fail to Improve Adherence
03/20/2017
Simple, low-cost medication reminder tools for long-term prescriptions have no significant effect on adherence rates of patients with various chronic illnesses.
Simple, low-cost medication reminder tools for long-term prescriptions have no significant effect on adherence rates of patients with various chronic illnesses.
Simple, low-cost medication...
03/20/2017
First Report Managed Care
News Connection
Shift to Same-Day Cardiac Procedure Could Cut $300 Million Annually
03/20/2017
US hospitals could save by shifting percutaneous coronary intervention procedures to transradial, same-day discharge procedures.
US hospitals could save by shifting percutaneous coronary intervention procedures to transradial, same-day discharge procedures.
US hospitals could save by...
03/20/2017
First Report Managed Care
News Connection
Ozanimod Prevents Multiple Sclerosis Relapse in Phase 3 Trial
03/20/2017
Multiple sclerosis patients treated with ozanimod, a selective S1P 1 and 5 receptor modulator, were less likely to relapse than those treated with weekly Avonex.
Multiple sclerosis patients treated with ozanimod, a selective S1P 1 and 5 receptor modulator, were less likely to relapse than those treated with weekly Avonex.
Multiple sclerosis patients...
03/20/2017
First Report Managed Care
News Connection
Lynparza Tablets Show Promise for BRCA-Mutated Metastatic Breast Cancer
03/20/2017
Compared with standard chemotherapy, Lynparza provided an improvement in progression-free survival of patients with HER2-negative metastatic breast cancer.
Compared with standard chemotherapy, Lynparza provided an improvement in progression-free survival of patients with HER2-negative metastatic breast cancer.
Compared with standard...
03/20/2017
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Improving Health Outcomes Through Early COPD and Asthma Intervention
10/04/2024
Hannah Musick
Research published in the New England Journal of Medicine shows that early diagnosis and treatment of undiagnosed COPD or asthma can reduce health care utilization for respiratory illness and improve overall health outcomes.
Research published in the New England Journal of Medicine shows that early diagnosis and treatment of undiagnosed COPD or asthma can reduce health care utilization for respiratory illness and improve overall health outcomes.
Research published in the New...
10/04/2024
First Report Managed Care
News
Advances in Factor IX Therapy Offer New Hope for Hemophilia B Treatment
10/23/2024
Lisa Kuhns, PhD, MD
New factor IX therapies promise improved treatment for hemophilia B.
New factor IX therapies promise improved treatment for hemophilia B.
New factor IX therapies promise...
10/23/2024
First Report Managed Care
News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
Jolynn Tumolo
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
Risk of Psychiatric Comorbidity Higher in Patients With Ankylosing Spondylitis
05/19/2023
Jolynn Tumolo
Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.
Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.
Findings from a...
05/19/2023
First Report Managed Care
Conference Coverage
Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens
06/08/2023
Maria Asimopoulos
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug...
06/08/2023
First Report Managed Care

March 2017 Volume 14 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use